Sotera Health Company (SHC)

Sotera Health Company Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,107	1,100	1,049	1,004	931.48	818.16
Revenue Growth (YoY)	2.78%	4.88%	4.54%	7.75%	13.85%	5.12%
Cost of Revenue	496.18	498.15	472.13	446.68	412.81	374.59
Gross Profit	610.61	602.3	577.16	557	518.67	443.57
Selling, General & Admin	203.44	204.75	186.37	166.18	149.36	136.6
Operating Expenses	265.07	266.79	250.16	229.12	213.14	195.63
Operating Income	345.54	335.51	326.99	327.89	305.53	247.94
Interest Expense	-163.8	-164.69	-142.88	-80.14	-74.19	-215.26
Currency Exchange Gain (Loss)	-1.06	-0.2	-0.16	-0.15	-1.35	5.23
Other Non Operating Income (Expenses)	1.14	0.12	2.38	-0.46	3.56	4.16
EBT Excluding Unusual Items	181.83	170.74	186.34	247.14	233.55	42.07
Gain (Loss) on Sale of Investments	-	-	-	-9.61	-	-
Legal Settlements	-69.63	-32.69	-80.31	-480.64	-45.66	-36.67
Other Unusual Items	-24.17	-24.17	-	-	-15.58	-44.26
Pretax Income	88.04	113.87	106.03	-243.11	175.72	-38.86
Income Tax Expense	63.22	69.48	54.65	-9.54	58.6	-1.37
Earnings From Continuing Operations	24.82	44.4	51.38	-233.57	117.12	-37.49
Minority Interest in Earnings	-	-	-	-	-0.24	-1.13
Net Income	24.82	44.4	51.38	-233.57	116.88	-38.62
Preferred Dividends & Other Adjustments	0.04	0.06	0.29	-	1.52	-
Net Income to Common	24.78	44.34	51.09	-233.57	115.36	-38.62
Net Income Growth	-54.76%	-13.58%	-	-	-	-
Shares Outstanding (Basic)	283	283	281	280	279	238
Shares Outstanding (Diluted)	285	285	283	280	279	238
Shares Change (YoY)	0.45%	0.60%	1.12%	0.26%	17.54%	2.28%
EPS (Basic)	0.09	0.16	0.18	-0.83	0.41	-0.16
EPS (Diluted)	0.09	0.16	0.18	-0.83	0.41	-0.16
EPS Growth	-53.92%	-12.89%	-	-	-	-
Free Cash Flow	105.89	45.09	-362.71	95.58	179.38	67.08
Free Cash Flow Per Share	0.37	0.16	-1.28	0.34	0.64	0.28
Gross Margin	55.17%	54.73%	55.01%	55.50%	55.68%	54.22%
Operating Margin	31.22%	30.49%	31.16%	32.67%	32.80%	30.30%
Profit Margin	2.24%	4.03%	4.87%	-23.27%	12.38%	-4.72%
Free Cash Flow Margin	9.57%	4.10%	-34.57%	9.52%	19.26%	8.20%
EBITDA	512.12	501.78	487.33	475.63	458.68	393.5
EBITDA Margin	46.27%	45.60%	46.44%	47.39%	49.24%	48.10%
D&A For EBITDA	166.58	166.28	160.34	147.75	153.15	145.56
EBIT	345.54	335.51	326.99	327.89	305.53	247.94
EBIT Margin	31.22%	30.49%	31.16%	32.67%	32.80%	30.30%
Effective Tax Rate	71.81%	61.01%	51.54%	-	33.35%	-
Revenue as Reported	1,107	1,100	1,049	1,004	931.48	818.16

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q